News

Published on 20 Aug 2024 on Insider Monkey · via Yahoo Finance

AbCellera Biologics Inc. (ABCL): The Best Multibagger Penny Stock of 2025?


Article preview image

We recently compiled a list of the 10 Best Multibagger Penny Stocks of 2025. In this article, we are going to take a look at where AbCellera Biologics Inc. (NASDAQ:ABCL) stands against the other multibagger penny stocks.

What Are Multibagger Stocks And How To Identify Them

The term "multibagger" was coined by Peter Lynch in his book titled "One Up On Wall Street" to describe those stocks whose share prices increase several times more than an investor's original investment. Typically, a multibagger stock is one that can be expected to rise by 100% or more - a huge number that warrants the immense attention investors are giving to multibagger stocks today. Lynch himself is an American investor who managed the Magellan Fund at Fidelity Investments from 1977 to 1990. On multibagger stocks, Lynch noted in his book that these are typically fast-growing companies with the potential to yield significant returns over time. He thus considers investment portfolios that own a diverse variety of numerous stocks to be better placed to benefit from multibagger stocks and their growth, in stark contrast to those portfolios that are overly concentrated on investing in a few companies.

NASDAQ.ABCL price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
AbCellera Biologics Inc. (NASDAQ:ABCL) most popular amongst individual investors...

There are a reasonable number of analysts covering the stock, so it might be useful to find out...

Simply Wall St. · via Yahoo Finance 20 Jan 2025

AbCellera Biologics Inc. (ABCL): A Bull Case Theory

We came across a bullish thesis on AbCellera Biologics Inc. (ABCL) on Twitter by Jack Prescott. I...

Insider Monkey · via Yahoo Finance 17 Jan 2025

Is AbCellera Biologics Inc. (ABCL) Among the Best Canadian Penny Stocks to Buy...

We recently published a list of the 12 Best Canadian Penny Stocks to Buy According to Analysts. I...

Insider Monkey · via Yahoo Finance 7 Jan 2025

AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating...

Revenue: Approximately $7 million for Q3 2024, consistent with Q3 2023. Research and Development...

GuruFocus.com · via Yahoo Finance 5 Nov 2024

AbCellera Biologics Inc (ABCL) Q3 2024: Everything You Need To Know Ahead Of...

AbCellera Biologics Inc (NASDAQ:ABCL) is set to release its Q3 2024 earnings on Nov 4, 2024. The...

GuruFocus.com · via Yahoo Finance 1 Nov 2024

Is AbCellera Biologics Inc. (ABCL) the Penny Stock with the Biggest Upside...

In this article, we will look at the 8 Penny Stocks with Biggest Upside Potential According to An...

Insider Monkey · via Yahoo Finance 16 Oct 2024

AbCellera Biologics Inc. (ABCL): A Top Contender Among Canada’s Best Penny...

We recently compiled a list of the 10 Best Canadian Penny Stocks to Buy Now. In this article, we ...

Insider Monkey · via Yahoo Finance 20 Aug 2024

AbCellera Biologics Inc. (ABCL): The Best Multibagger Penny Stock of 2025?

We recently compiled a list of the 10 Best Multibagger Penny Stocks of 2025. In this article, we ...

Insider Monkey · via Yahoo Finance 20 Aug 2024

Earnings Release: Here's Why Analysts Cut Their AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target...

It's been a good week for AbCellera Biologics Inc. (NASDAQ:ABCL) shareholders, because the compan...

Simply Wall St. via Yahoo Finance 10 May 2024

AbCellera Biologics Inc (ABCL) Q1 2024 Earnings: Misses Revenue and Net Loss Estimates

Revenue: Reported at $10.0 million, down from $12.2 million in Q1 2023, falling short of the esti...

GuruFocus.com via Yahoo Finance 9 May 2024